Short term stability of verbal memory impairment in mild cognitive impairment and Alzheimer's disease measured using the International Shopping List Test

There is a need for culture neutral neuropsychological instruments. The International Shopping List Test (ISLT) is sensitive to memory impairment in Alzheimer's disease (AD) in different cultural groups, although its sensitivity to mild cognitive impairment (MCI) and ability to be given repeatedly at short retest intervals is unknown. Performance on the ISLT was compared between groups of healthy adults, MCI, and AD from the Australian Imaging Biomarkers and Lifestyle study of ageing. Subjects were assessed four times in three months. In each group, the ISLT performance measures had high test–retest reliability, and group means remained stable over time. There was no difference between groups on within-subject variability. These data suggest that in English-speaking samples, the ISLT is sensitive to MCI and can be given repeatedly in order to assess change in memory.

[1]  D. Salmon,et al.  Therapy for Specific Problems Therapy for Specific Problems : Youth Tobacco Cessation , 2009 .

[2]  D. Delis,et al.  California Verbal Learning Test--Second Edition , 2016 .

[3]  P. Snyder,et al.  Preliminary data on the effect of culture on the assessment of Alzheimer's disease-related verbal memory impairment with the International Shopping List Test. , 2012, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[4]  H. Buschke,et al.  Sensitivity and test-retest reliability of the international shopping list test in assessing verbal learning and memory in mild Alzheimer's disease. , 2011, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[5]  Ronald C. Petersen,et al.  Assessment of cognition in mild cognitive impairment: A comparative study , 2011, Alzheimer's & Dementia.

[6]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[7]  C. Rowe,et al.  Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging , 2010, Neurobiology of Aging.

[8]  A. Hinton-Bayre.  Deriving reliable change statistics from test-retest normative data: comparison of models and mathematical expressions. , 2010, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[9]  C. Rowe,et al.  Relationship between atrophy and β‐amyloid deposition in Alzheimer disease , 2010, Annals of neurology.

[10]  P. Snyder,et al.  A method for cross-cultural adaptation of a verbal memory assessment , 2009, Behavior research methods.

[11]  P. Snyder,et al.  A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia , 2009, Journal of clinical and experimental neuropsychology.

[12]  C. Rowe,et al.  The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease , 2009, International Psychogeriatrics.

[13]  Sonja Zehetmayer,et al.  Prediction of Alzheimer dementia with short neuropsychological instruments , 2009, Alzheimer's & Dementia.

[14]  Celeste A de Jager,et al.  Detection of MCI in the clinic: evaluation of the sensitivity and specificity of a computerised test battery, the Hopkins Verbal Learning Test and the MMSE. , 2009, Age and ageing.

[15]  Martin Koller,et al.  A neuropsychological test battery for use in Alzheimer disease clinical trials. , 2007, Archives of neurology.

[16]  A. de Mendonça,et al.  Verbal learning and memory deficits in Mild Cognitive Impairment , 2007, Journal of clinical and experimental neuropsychology.

[17]  M. Albert,et al.  The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease. , 2006, Archives of neurology.

[18]  D. Delis,et al.  The California Verbal Learning Test--second edition: test-retest reliability, practice effects, and reliable change indices for the standard and alternate forms. , 2006, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[19]  M. Weiner,et al.  Patterns of Verbal Memory Performance in Mild Cognitive Impairment, Alzheimer Disease, and Normal Aging , 2006, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[20]  H. Buschke,et al.  Retention weighted recall improves discrimination of Alzheimer's disease , 2006, Journal of the International Neuropsychological Society.

[21]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[22]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[23]  M. Albert,et al.  Amnestic MCI or prodromal Alzheimer's disease? , 2004, The Lancet Neurology.

[24]  P. Tremblay,et al.  Practice Effect and Test-Retest Reliability of Attentional and Executive Tests in Middle-Aged to Elderly Subjects , 2004, The Clinical neuropsychologist.

[25]  J. Kulisevsky,et al.  Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging , 2003, International journal of geriatric psychiatry.

[26]  Paul Maruff,et al.  The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals. , 2003, Journal of the International Neuropsychological Society : JINS.

[27]  J. Baños,et al.  California Verbal Learning Test-Second Edition , 2002 .

[28]  B. Axelrod,et al.  Practice Effects on the WAIS-III Across 3- and 6-Month Intervals , 2002, The Clinical neuropsychologist.

[29]  K. Christensen,et al.  Facial Recognition Test in the Elderly: Norms, Reliability and Premorbid Estimation , 2002, The Clinical neuropsychologist.

[30]  H. Westervelt,et al.  Practice effects, test-retest stability, and dual baseline assessments with the California Verbal Learning Test in an HIV sample. , 2001, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[31]  D P Salmon,et al.  Comparison of the serial position effect in very mild Alzheimer's disease, mild Alzheimer's disease, and amnesia associated with electroconvulsive therapy , 2000, Journal of the International Neuropsychological Society.

[32]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[33]  K. Boone,et al.  Handbook of Normative Data for Neuropsychological Assessment , 1999 .

[34]  R. Benedict,et al.  Practice effects during repeated administrations of memory tests with and without alternate forms. , 1998, Journal of clinical and experimental neuropsychology.

[35]  Ralph H. B. Benedict,et al.  Hopkins Verbal Learning Test—Revised: Normative data and analysis of inter-form and test–retest reliability. , 1998 .

[36]  J. Morris.  The Clinical Dementia Rating (CDR) , 1993, Neurology.

[37]  H. Levin.  A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary , 1993 .

[38]  N. Jacobson,et al.  Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. , 1991, Journal of consulting and clinical psychology.

[39]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[40]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[41]  H. Hartley,et al.  The use of range in analysis of variance. , 1950, Biometrika.

[42]  Nick C. Fox,et al.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging and Alzheimer's Association workgroup , 2011 .

[43]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup , 2011 .

[44]  J. Lani.  Rey Auditory Verbal Learning Test (RAVLT) , 2010 .

[45]  Sylvie Belleville,et al.  Characterizing the memory changes in persons with mild cognitive impairment. , 2008, Progress in brain research.

[46]  John C Morris,et al.  Mild cognitive impairment is early-stage Alzheimer disease: time to revise diagnostic criteria. , 2006, Archives of neurology.

[47]  P. Maruff,et al.  Age-Related Memory Impairment. , 2006 .

[48]  K. Boone,et al.  Handbook of normative data for neuropsychological assessment, 2nd ed. , 2005 .

[49]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[50]  O. Spreen,et al.  A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary , 1991 .

[51]  M Haupt,et al.  [Clinical diagnosis of Alzheimer's disease]. , 1988, Deutsche medizinische Wochenschrift.

[52]  G. Huston.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[53]  Vijaya L. Melnick,et al.  Alzheimer’s Dementia , 1985, Contemporary Issues in Biomedicine, Ethics, and Society.